Last updated on August 2019

Study to Patients With Stable COPD to Assess the Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate (DUAKLIR)


Brief description of study

This is a multiple dose, randomised, parallel, double blind, double dummy, multicentre and multinational Phase III study to determine the efficacy and safety of Aclidinium bromide/Formoterol fumarate compared with individual components and placebo and Aclidinium bromide compared with Placebo when administered to patients with stable Chronic Obstructive Pulmonary Disease (COPD).

Clinical Study Identifier: NCT03022097

Find a site near you

Start Over

Research Site

Changchun, China
  Connect »

Research Site

Chongqing, China
  Connect »

Research Site

Guangzhou, China
  Connect »

Research Site

Shengyang, China
  Connect »

Research Site

Shijiazhuang, China
  Connect »

Research Site

Zhanjiang, China
  Connect »

Research Site

Ahmedabad, India
  Connect »

Research Site

Alappuzha, India
  Connect »

Research Site

Bangalore, India
  Connect »

Research Site

Ernakulam District, India
  Connect »

Research Site

Kozhikode, India
  Connect »

Research Site

Vijayawada, India
  Connect »

Research Site

Vijaywada, India
  Connect »

Research Site

Caloocan City, Philippines
  Connect »

Research Site

Iloilo City, Philippines
  Connect »

Research Site

Manila, Philippines
  Connect »

Research Site

Quezon City, Philippines
  Connect »

Research Site

Taichung City, Taiwan
  Connect »

Research Site

Taichung, Taiwan
  Connect »

Research Site

Ho Chi Minh City, Vietnam
  Connect »

Research Site

Ho Chi Minh, Vietnam
  Connect »

Research Site

Liangyugang, China
  Connect »